6Mo·

Hot biotechnology trade

Today I added $KYTX in the depot today. New study data is expected on 21.22.04. If they are positive, which there are many indications of after the great results in December $KYTX will apply for approval in the first half of the year and, due to its fast track status, will receive approval for Miv-Cel before the end of the year.

09.04

KYT

Kyverna

Acheté à 9,22 $US

5 Commentaires

NichtRelevant@NichtRelevant

6Mo

Biotech is your new hobbyhorse alongside commodities 🙂

•

Chris@Multibagger

6Mo

@NichtRelevant Yes, that is the case.

•

Chris@Multibagger

6Mo

@NichtRelevant However, I had already announced in my annual outlook at the end of last year that I see these two sectors as the most promising in 2026

•

NichtRelevant@NichtRelevant

6Mo

@Multibagger I also find biotech very exciting, but with start-ups and smaller companies in particular, a lot often depends on one or two potential product developments and the associated studies. You have to stay on the ball - it's not something you can blindly leave lying around for a long time.

Ultimately, however, it's not a bad thing if you're speculating and are prepared to invest time in research.

For me - where I am not informed on a daily basis - I am instead betting on the big 'buyers' in this area, at the moment $PFE (Pfizer) and $AMGN (Amgen).

•

Chris@Multibagger

6Mo

@NichtRelevant That's right, that's why I sold $GPCR and $NKTR after the sharp rises and am now only buying them again via a savings plan in my Biotech Pie at Trading 212. And I currently have around 15 biotech stocks in my portfolio. It is unlikely that they will all fail.

••